Validation Fund/SPARK-BIH Projects

Since 2018, 27 teams (13 Track 1, 14 Track 2) and their translational projects have received funding and mentoring from the Validation Fund/SPARK-BIH program. 3 teams were invited to participate in the I4H program.

+++ More detailed information and a complete list of our 2018 and 2019 SPARKees and their translational projects will follow soon. +++

Testimonials from our SPARKees

"For a scientist pursuing hypothesis-driven basic research SPARK means a fundamental shift of perspective: Peer to peer guidance to stay on target for converting basic research into drugs ready for business and clinical application."

Prof. Dr. Regine Heilbronn, Director Institute of Virology CBF, Charité – Universitätsmedizin Berlin

"When first invited, I came for money. Now I come for priceless expertise and multi-level support"

Prof. Dr. Christoph Schwarzer, Institute of Pharmacology, Medical University Innsbruck (Team: Prof. Dr. Regine Heilbronn)

"SPARK is a great initiative to de-risk innovative projects and to enhance translational research from bench to bedside. SPARK provided us with excellent partners, pushed our project and helped a lot in making decisions and focusing on the next step."

"The monetary support by the validation fund helped to advance the evaluation and optimization of our compound. Furthermore, the SPARK team and advisors were very helpful to outline our future project strategy."

"The monetary and SPARK mentoring support were both essential to move our project forward. The support helped us to succeed the critical steps needed for IP generation and enabled further collaborations in different clinical indications." 

PD Dr. med. Karoline Krause, Dpt. of Dermatology and Allergy, Allergie-Centrum-Charité, Charité – Universitätsmedizin Berlin

"I was so excited to participate in the SPARK mentoring program, because it provides a completely new perspective on the clinical translation of projects. For scientists it is so important to get insights into the process of translating basic research findings into treatments. These insights provided by the SPARK program definitely shaped my way of thinking about current scientific projects and future ideas."

Dr. Felix Lorenz, Captain T Cell, Molecular Cell Biology and Gene Therapy, Max-Delbrück-Center for Molecular Medicine (MDC) Berlin

"With the help of the SPARK program we could refocus our priorities and were able to advance our project from an idea to a finished trial protocol."

PD Dr. Wolfgang Böhmerle, Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin

"Without financial support, the project would not have been possible and the fantastic SPARK team helped us to achieve tremendous progress in a structured and well-focues way."

Dr. Kostja Renko, AG Prof. Dr. Lutz Schomburg, Institute of Experimental Endocrinology, Charité - Universitätsmedizin Berlin